Holding announcement according to article 135 section 2 BörseG (ESMA 2015/1597)
Marinomed Biotech AG: Correction of a Release according to art. 135 section 2 BörseG from 25.01.2021
Korneuburg (pta023/26.01.2021/12:19 UTC+1) - Release of Announcement according to article 135 section 2 BörseG
Notification of Major Holdings
1. Issuer
Marinomed Biotech AG, Hovengasse 25, 2100 Korneuburg, Austria
2. Reason for notification
Acquisition / disposal of shares with voting rights
3. Details of person subject to the notification obligation
Name: Acropora Beteiligungs GmbH
City and country of registered office:
Vienna,
Austria
4. Names of shareholders, if different from declarants (3)
Mohammed Al Sheikh
Abdulmohsen Al Sheikh
5. Date on which threshold was crossed or reached
21.01.2021
6. Total positions
| % of voting rights attached to shares (total of 7.a.) | % of voting rights through instruments (total of 7.b.1 + 7.b.2) | total of both in % (7.a. + 7.b.) | total number of voting rights of issuer | |
|---|---|---|---|---|
| Resulting situation on the date on which threshold was crossed / reached | 13,86 | n/a | 13,86 | 1,474,731 |
| Position of previous notification | 16,59 | 0,00 | 16,59 |
7. Notified details of the resulting situation
7.A: Voting rights attached to shares
| ISIN code | absolute direct (Sec 130 BörseG 2018) | absolute indirect (Sec 133 BörseG 2018) | in % direct (Sec 130 BörseG 2018) | in % indirect (Sec 133 BörseG 2018) |
|---|---|---|---|---|
| ATMARINOMED6 | 0 | 204,410 | 0.00 | 13.86 |
| Total: | 204,410 | 13.86 |
7.B.1: Financial / Other Instruments pursuant to Sec. 131 para. 1 No. 1 BörseG 2018
| type of instrument | Maturity / Expiration | Exercise or conversion period | Voting Rights Absolute | Voting Rights in % |
|---|---|---|---|---|
| Total: | 0 | 0 |
7.B.2: Financial / Other Instruments pursuant to Sec. 131 para. 1 No. 2 BörseG 2018
| type of instrument | Maturity / Expiration | Exercise or conversion period | Cash or physical transaction | Voting Rights Absolute | Voting Rights in % |
|---|---|---|---|---|---|
| Total: | 0 | 0 |
8. Information in relation to the person subject to the notification obligation
Full chain of controlled undertakings through which the voting rights and/or the financial/other instruments are effectively held starting with the ultimate controlling natural person or legal entity.
| No. | Name | Directly controlled by No. | Shares held directly (%) | Financial/other instruments held directly (%) | Total of both (%) |
|---|---|---|---|---|---|
| 1 | Abdulmohsen Al Sheikh | n/a | n/a | n/a | |
| 2 | Mohammed Al Sheikh | n/a | n/a | n/a | |
| 3 | Acropora Beteiligungs GmbH | 1,2 | 13,86 | n/a | 13,86 |
9. In case of proxy voting
Date of general meeting: N/A
Voting rights after general meeting:
10. Other useful information
The participation notification is based on the fact that the threshold is not reached after the sale of 38,450 shares.
(end)
| Emitter: |
Marinomed Biotech AG Hovengasse 25 2100 Korneuburg Austria |
|
|---|---|---|
| Contact Person: | Elisabeth Schön | |
| Phone: | +43226290300 | |
| E-Mail: | elisabeth.schoen@marinomed.com | |
| Website: | www.marinomed.com | |
| ISIN(s): | ATMARINOMED6 (Share) | |
| Stock Exchange(s): | Vienna Stock Exchange (Official Trade) |